Immunic, Inc.

US$7.75As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:IMUXHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (31.84%)
Div yield —
ROE (138.17%)
Biotechnology
Beta (5Y) 1.48
PE TTM —
TSR TTM (0.49%)
Mkt cap US$105.7M
ROIC (90.38%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.81
26.59%
4.22%
Hold 7|0|9|10|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.10
0.11
0.11
(0.80%)
(8.23%)
5.17%
15.01%
Revenue$M
10.16
10.48
10.88
11.28
10.77%
9.56%
8.30%
12.16%
Peers (US$105.7M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.114
0.245
0.203
EBIT/Intx
0.730
0.404
0.389
Own earn%
128.84
14.71
32.79
Sh yield%
42.84
32.60
32.26
Owners
Insiders/Inst%
14.32
72.30
Short interest%
2.30
SBC / revenue%
2.27
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
30–34
$1 testx
—
Incr. ROIC%
6